Arecor Therapeutics plc (AREC) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
69.50p
67.00p
185.00p
£26.24 million
69.50p
67.00p
62.50p
n/a
0.00p (0.00%) Previous:
0.00p
25,000
n/a
1,000
Performance
1 week 1W | 1.46% | 1 year 1Y | 61.92% |
---|---|---|---|
1 month 1M | 9.15% | 2 years 2Y | 71.04% |
3 months 3M | 1.46% | 3 years 3Y | 82.18% |
6 months 6M | 42.08% | 5 years 5Y | n/a |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | 4.57 | 2.40 |
Profit before tax (£m) | (8.90) | (10.54) |
Adjusted EPS (p): | (28.00) | (32.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Arecor Therapeutics shares tank on funding update
10 June 2024 07:52
-
Arecor subsidiary Tetris launching Ogluo in the Netherlands
29 February 2024 14:12
-
Arecor appoints new commercial manager to Tetris subsidiary
3 January 2024 13:44
-
Grant of Options and PDMR Dealing
2 December 2024 07:00
-
Arecor Appoints Interim Chief Financial Officer
18 November 2024 07:00
-
Interim Results for six months ended 30 June 2024
26 September 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.